Within the framework of Siric Curamus, Julia Tinland is conducting research on the development of personalised medicine and precision medicine and their impact on diagnostic categories and risk stratification, on the identification of people at very high and very low risk of progression. She is working on conceptualisations of vulnerability in the field of prevention and their ethical implications. It clarifies the tensions between public health and precision medicine. She is also leading the Damocles Test project on Chronic Lymphocytic Leukaemia (CLL) which focuses on the needs and expectations of diagnosed but asymptomatic patients.

Read also Julia Tinland's thesis.